A lot could happen on the trade front in the next few weeks, from pressuring Russia on Ukraine to arguing the legality of the ...

Amgen Inc. (NASDAQ:AMGN) is one of the high-margin pharma stocks to buy now. HSBC has lowered its price target on Amgen Inc.

President Trump is reportedly pushing for higher blanket tariffs on imports from the European Union, throwing a wrench in ...

Meanwhile, Australian Prime Minister Anthony Albanese has resisted U.S. calls for Australia to raise its defense spending ...

The average consumer could pay 75 percent more for a marketplace plan, according to a KFF analysis, driven by the expiration ...

The expiration of the enhanced ACA premium subsidies at the end of this year is prompting many insurers to hike rates by an ...

Despite former President Donald Trump’s threat of a 200% tariff on imported drugs during a cabinet meeting, pharmaceutical investors have shown surprisingly positive sentiment this week. Despite ...

Bessent's victory lap on tariff revenues was premature. And so are hopes that the trade war won't damage commerce and the U.S. economy.

CIO & PM of leading sector ETF explains what has been impacting leading names and why he still sees strong long-term ...

The Treasurer says he is evaluating the impact of US drug tariffs on the Pharmaceutical Benefits Scheme but says subsidies ...

Exporters from engineering, plastics and pharmaceuticals said delayed tariff decisions from Washington had stalled expansion plans, pushed back new US orders and clouded short-term growth.

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...